Michael Lim, MD of The Johns Hopkins Hospital @hopkinskimmel discusses the phase I trial of anti-LAG-3 alone and in combination with anti-PD-1 in patients with recurrent GBM.
Read here: https://meetinglibrary.asco.org/record/187521/abstract
Advertisement